1. Home
  2. MDXH vs CHMI Comparison

MDXH vs CHMI Comparison

Compare MDXH & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • CHMI
  • Stock Information
  • Founded
  • MDXH 2003
  • CHMI 2012
  • Country
  • MDXH Belgium
  • CHMI United States
  • Employees
  • MDXH N/A
  • CHMI N/A
  • Industry
  • MDXH
  • CHMI Real Estate Investment Trusts
  • Sector
  • MDXH
  • CHMI Real Estate
  • Exchange
  • MDXH Nasdaq
  • CHMI Nasdaq
  • Market Cap
  • MDXH 100.5M
  • CHMI 97.2M
  • IPO Year
  • MDXH 2021
  • CHMI 2013
  • Fundamental
  • Price
  • MDXH $1.77
  • CHMI $2.78
  • Analyst Decision
  • MDXH Strong Buy
  • CHMI Buy
  • Analyst Count
  • MDXH 2
  • CHMI 2
  • Target Price
  • MDXH $7.00
  • CHMI $5.00
  • AVG Volume (30 Days)
  • MDXH 98.8K
  • CHMI 214.8K
  • Earning Date
  • MDXH 11-06-2024
  • CHMI 11-12-2024
  • Dividend Yield
  • MDXH N/A
  • CHMI 21.58%
  • EPS Growth
  • MDXH N/A
  • CHMI N/A
  • EPS
  • MDXH N/A
  • CHMI N/A
  • Revenue
  • MDXH $84,708,000.00
  • CHMI N/A
  • Revenue This Year
  • MDXH $26.39
  • CHMI N/A
  • Revenue Next Year
  • MDXH $18.68
  • CHMI $12.15
  • P/E Ratio
  • MDXH N/A
  • CHMI N/A
  • Revenue Growth
  • MDXH 33.01
  • CHMI N/A
  • 52 Week Low
  • MDXH $0.35
  • CHMI $2.78
  • 52 Week High
  • MDXH $4.64
  • CHMI $4.39
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 26.20
  • CHMI 14.96
  • Support Level
  • MDXH $1.62
  • CHMI $3.21
  • Resistance Level
  • MDXH $2.24
  • CHMI $3.30
  • Average True Range (ATR)
  • MDXH 0.13
  • CHMI 0.10
  • MACD
  • MDXH -0.01
  • CHMI -0.04
  • Stochastic Oscillator
  • MDXH 28.57
  • CHMI 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

Share on Social Networks: